This book examines insights into the latest thinking and core concepts in areas of key methodological endeavor in Pharmacovigilance (PV), which strives to ever more effectively protect patients from harm caused by the medicines they need. Each book chapter tends to have a clear quantitative or clinical slant and an aim to provide an overview of methodological insights within a specific topic, while also providing a perspective on how the area is anticipated to develop in the future. Quantitative chapters focus more on statistical and epidemiological strategies and the thinking that underpins core developments in Pharmacovigilance, whereas clinical chapters focus on clinical methods for detecting hypotheses for and determining side effects of medicinal products as well as misdiagnosis pitfalls. Examples of areas of importance include signal detection, risk management, and risk benefit assessment.
| ISBN: | 9781493988167 |
| Publication date: | 26th October 2018 |
| Author: | Andrew Bate |
| Publisher: | Humana Press an imprint of Springer New York |
| Format: | Hardback |
| Pagination: | 275 pages |
| Series: | Methods in Pharmacology and Toxicology |
| Genres: |
Pharmacology |
This book examines insights into the latest thinking and core concepts in areas of key methodological endeavor in Pharmacovigilance (PV), which strives to ever more effectively protect patients from harm caused by the medicines they need. Each book chapter tends to have a clear quantitative or clinical slant and an aim to provide an overview of methodological insights within a specific topic, while also providing a perspective on how the area is anticipated to develop in the future.
Evidence-Based Pharmacovigilance features in the following genres: Pharmacology
Hardback. Not Available.
Evidence-Based Pharmacovigilance was written by Andrew Bate and published by Humana Press an imprint of Springer New York
Evidence-Based Pharmacovigilance has 275 pages
Yes it is part of Methods in Pharmacology and Toxicology series